Genetic sequencing spinout Oxford Nanopore is the latest to be hit by the Woodford saga, with reports that the fund manager is looking to sell off its stake.
Woodford Investment Management, the beleaguered fund manager founded by Neil Woodford, is considering the disposal of its stake in University of Oxford’s genetic sequencing technology developer Oxford Nanopore Technologies, Sky News reported yesterday.
Sky News claimed Woodford would move in coming days to appoint PJT Park Hill, part of investment bank PJT Partners, as an adviser to sell off its stakes in Oxford Nanopore and digital bank Atom Bank.
Sources told the news broadcaster that Oxford Nanopore and Atom Bank, as well as cancer care provider Proton Partners International, were among the portfolio companies in Woodford’s suspended Equity Income Fund, whose corpus has been reduced by refunds to a number of a major investors.
However Neil Woodford is expected to stand firm on Oxford Nanopore’s market rate, despite the liquidity threat hanging over his company. An unnamed source remarked: “Anyone expecting a fire-sale of these holdings should…
